Cancer. Developing molecular biomarkers for cancer.
Ransohoff
David F
DF
Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7080, USA. ransohof@med.unc.edu
D014408:Biomarkers, Tumor / Q000032:analysis; D003106:Colon / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000235:genetics; D019175:DNA Methylation; D020869:Gene Expression Profiling; D020868:Gene Silencing; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D018392:Genomic Imprinting; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D007413:Intestinal Mucosa / Q000378:metabolism; D013058:Mass Spectrometry; D009154:Mutation; D009369:Neoplasms / Q000175:diagnosis* / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis; D011379:Prognosis; D020543:Proteome; D040901:Proteomics
D014408:Biomarkers, Tumor; D020543:Proteome; D007335:Insulin-Like Growth Factor II